TXG — 10X Genomics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual balance sheet for 10X Genomics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	587	430	389	393	523
Net Total Accounts Receivable
Net Total Receivables	85.3	104	115	87.9	82.5
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	748	635	596	584	684
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	230	359	345	310	287
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	1,019	1,029	965	919	1,041
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	110	131	127	118	153
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	201	223	224	209	245
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	818	806	741	710	796
Total Liabilities & Shareholders' Equity	1,019	1,029	965	919	1,041
Total Common Shares Outstanding